Immediate Impact
9 by Nobel laureates 2 from Science/Nature 64 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
2025 Standout
Works of Timothy Carll being referenced
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Timothy Carll | 48 | 162 | 100 | 76 | 24 | 331 | |
| Özden Vural | 109 | 58 | 72 | 56 | 18 | 301 | |
| Kashyap Patel | 23 | 54 | 108 | 24 | 32 | 259 | |
| Jason P. Cooper | 65 | 26 | 34 | 105 | 22 | 298 | |
| María N. Barrachina | 102 | 44 | 27 | 111 | 20 | 285 | |
| Ana Belén Moreno‐Castaño | 57 | 30 | 65 | 70 | 24 | 274 | |
| Kathryn Hally | 72 | 29 | 133 | 97 | 23 | 297 | |
| Muhua Cao | 70 | 24 | 132 | 158 | 17 | 358 | |
| J Böhm | 90 | 98 | 30 | 75 | 18 | 354 | |
| Fang Zhou | 60 | 33 | 31 | 157 | 26 | 332 | |
| Kathleen Madden | 14 | 162 | 56 | 108 | 21 | 279 |
All Works
Login with ORCID to disown or claim papers
Loading papers...